7 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... infection Episode #Pharmacology ... #Management #CDiff ... IDSA2017 #Adjunct #Antibiotics
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
antibiotics used ... ampicillin #management ... #coverage #antibiogram ... #pharmacology ... #table #sensitivities
Antibiotics for Anaerobic Bacteria 
 - Metronidazole (Flagyl™) 
 - Carbapenems 
 - β lactam +
Antibiotics for ... out of favor for treatment ... Anaerobic #Bacteria #Pharmacology ... #Table #Susceptibility ... #Coverage #Management
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Outpatient Treatment ... fluoroquinolone #IDSA ... Acquired #Pneumonia #Antibiotics ... #Management #Guidelines ... #pharmacology
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
anidulafungin; CAS ... fluconazole; ISA ... #Antifungal #antibiogram ... #management #pharmacology ... #spectrum #coverage
For my UME micro course, I made a figure that captures this terminology and lets learners
We can combine these ... #coverage #antibiogram ... #pharmacology # ... management #spectrum ... #table #sensitivities
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Potential Treatment ... Agents for Treatment ... × 10 days #CDiff ... #management #pharmacology ... #idsa #table